COHN vs JAZZ · P/E 2.5, rev $127.4M vs P/E 1988, rev $2.28B
Cohen & Company Inc (COHN) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Cohen & Company Inc (COHN) is a capital markets company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported COHN revenue for 2026-06-30 was $127.4M. Net income was $5.1M. COHN currently screens at market cap $28.8M and trailing P/E 2.5.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
COHN currently screens at market cap $28.8M and trailing P/E 2.5. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the COHN and JAZZ stock pages for the full models.
Not investment advice.